BSE filing, NSE: SREEL. Summary written from the filing by ALFA Finder's alert engine.
Sreeleathers Ltd: key numbers
- Share price
- ₹260.00
- Market cap
- ₹602.0 Cr
- Revenue (annual)
- ₹248.4 Cr
- Net profit (annual)
- ₹28.74 Cr
- P/E (TTM)
- 18.4×Sector 62.0×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 7.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sreeleathers Ltd
All →Sreeleathers Management Change
Sreeleathers Limited has changed the designation of Mr. Soham Dey from Additional Director to Executive Director, effective September 28, 2026.
Sreeleathers Annual General Meeting
Sreeleathers Limited held its 35th Annual General Meeting on September 28, 2026. The meeting discussed the financial performance and various ordinary and special business resolutions.
Sreeleathers Annual General Meeting
Sreeleathers Limited has issued a notice for its 35th Annual General Meeting, scheduled for September 28, 2026, to conduct four agenda items.
Sreeleathers Other Announcement
Sreeleathers Limited informed shareholders about accessing the 35th AGM notice and FY 2025-26 Annual Report via web links due to non-registered email addresses.
Sreeleathers Dividend
Sreeleathers Limited has announced book closure dates for its 35th Annual General Meeting and declared a final dividend of ₹1 per share.
Sreeleathers Annual General Meeting
Sreeleathers Limited will hold its 35th Annual General Meeting on September 28, 2026. The meeting will be conducted virtually via video conferencing at 11:30 a.m.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.